Clark Capital Management Group, Inc. - BIOSPECIFICS TECHNOLOGIES CO ownership

BIOSPECIFICS TECHNOLOGIES CO's ticker is BSTC and the CUSIP is 090931106. A total of 118 filers reported holding BIOSPECIFICS TECHNOLOGIES CO in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Clark Capital Management Group, Inc. ownership history of BIOSPECIFICS TECHNOLOGIES CO
ValueSharesWeighting
Q4 2019$1,708,000
+23.9%
29,995
+16.4%
0.04%
+16.1%
Q3 2019$1,379,000
-13.1%
25,765
-3.0%
0.03%
-6.1%
Q2 2019$1,586,000
-31.4%
26,557
-28.4%
0.03%
-40.0%
Q1 2019$2,311,00037,0840.06%
Other shareholders
BIOSPECIFICS TECHNOLOGIES CO shareholders Q1 2019
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 285,259$16,685,0009.76%
JW Asset Management, LLC 73,649$4,308,0002.32%
THB ASSET MANAGEMENT 113,485$6,637,0000.81%
Eversept Partners, LP 21,900$1,280,9310.56%
EAM Global Investors LLC 20,642$1,207,0000.49%
RICE HALL JAMES & ASSOCIATES, LLC 181,690$10,627,0000.38%
Elk Creek Partners, LLC 114,230$6,681,0000.36%
ISTHMUS PARTNERS, LLC 19,525$1,142,0000.29%
PURA VIDA INVESTMENTS, LLC 20,160$1,179,0000.25%
CADENCE CAPITAL MANAGEMENT LLC 49,363$2,887,0000.16%
View complete list of BIOSPECIFICS TECHNOLOGIES CO shareholders